Join or renew today
Clinical literature is filled with questionable evidence and poor data quality reported in randomized controlled clinical trials and observational studies. It is critical that journalists have the skills to navigate the system and independently evaluate the quality of evidence. Clinical decisions may be based on inappropriate methods unless questioned and addressed by skilled journalists.
Health journalists in particular have an obligation and opportunity to tease the threads of innovation, drug discovery, and regulatory environments to provide informed context and a powerful narrative.
This is particularly critical when evaluating studies regarding older adults and other vulnerable groups. When reviewing methodology, these factors should be taken into consideration.
The page you have requested is available to AHCJ members only. If you are
a member, please login below.
If you're not a member, we invite you to join us. Read about member
benefits and how to join.
Please provide your user ID and password below:
~ or ~
Log in by email, using your email address: